We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Buckyballs to Fight Allergies

By Biotechdaily staff writers
Posted on 05 Jul 2007
Investigators identified a new biologic function for a molecule called a bucky ball--the ability to block the allergic response, setting the stage for the development of new therapies for allergy.

Allergic disease is the sixth leading cause of chronic disease in the United States, and while various treatments have been developed to control allergy, no cure has been found. More...
These findings advance the emerging field of medicine known as nanoimmunology. The researchers, from Virginia Commonwealth University (VCU; Richmond, VA, USA) and Luna Innovations, Inc. (Roanoke, VA, USA), a research company, are the first to demonstrate that buckyballs are able to block allergic response in human cell culture experiments.

Buckyballs, or fullerenes, are molecules composed entirely of carbon. Due to their unique structure, inertness and stability, researchers from a number of scientific fields have been investigating the tiny, hollow carbon cages to serve a variety of functions. In this study, scientists modified the buckyballs so that they were compatible with water.

"This discovery is exciting because it points to the possibility that these novel materials can one day lead to new therapies,” said Chris Kepley, Ph.D., M.B.A., assistant professor in the department of internal medicine, division of rheumatology, allergy, and immunology at the VCU School of Medicine. "Researchers in many fields are aware of the potential fullerenes have, however, we are the first to show they can turn off the allergic response and basic immune reactions.”

According to Dr. Kepley, who is the lead author of the study, the buckyballs are able to ‘interrupt' the allergy/immune response by suppressing a fundamental process in the cell that leads to the release of an allergic mediator. In essence, the buckyballs are able to prevent mast cells from releasing histamine.

Mast cells are responsible for causing allergic response and are stuffed with granules containing histamine. They are present in nearly all tissues except blood. When mast cells are triggered, inflammatory substances such as histamine, heparin, and a number of cytokines are quickly released into the tissues and blood, promoting an allergic response.
The researchers discovered that the unique structure of the buckyball enables it to bind to free radicals dramatically better than any anti-oxidant currently available, such as vitamin E. Free radicals are molecules that cause oxidative stress, which scientists believe may be the basis of aging.

The immune system both protects us and causes harm, so we are always interested in finding new pathways to help manage the harmful effects, said Dr. Kepley.

The new study findings were published online in the June 19, 2007, issue of the Journal of Immunology.


Related Links:
Luna Innovations Inc.
Virginia Commonwealth University

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.